<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7600111</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5310</journal-id>
<journal-id journal-id-type="nlm-ta">J Neurosci Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci. Res.</journal-id>
<journal-title-group>
<journal-title>Journal of neuroscience research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0360-4012</issn>
<issn pub-type="epub">1097-4547</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27557736</article-id>
<article-id pub-id-type="pmc">5513674</article-id>
<article-id pub-id-type="doi">10.1002/jnr.23900</article-id>
<article-id pub-id-type="manuscript">NIHMS808618</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Heterogeneity in Oligodendroglia: Is it Relevant to Mouse Models and Human Disease?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ornelas</surname>
<given-names>Isis M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLane</surname>
<given-names>Lauren E.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saliu</surname>
<given-names>Aminat</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evangelou</surname>
<given-names>Angelina V.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khandker</surname>
<given-names>Luipa</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wood</surname>
<given-names>Teresa L.</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Department of Pharmacology, Physiology &amp; Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Dr. Teresa L. Wood, Department of Pharmacology, Physiology &amp; Neuroscience, New Jersey Medical School and Cancer Center, Rutgers University, 205 South Orange Avenue, Newark, NJ 07101, USA, <email>Terri.wood@rutgers.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Conflict of Interest Statement:</bold>
</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>94</volume>
<issue>12</issue>
<fpage>1421</fpage>
<lpage>1433</lpage>
<!--elocation-id from pubmed: 10.1002/jnr.23900-->
<abstract>
<p id="P1">There are many lines of evidence indicating that OPC and oligodendrocyte populations in the CNS are heterogeneous based on their developmental origins as well as from morphological and molecular criteria. Whether these distinctions reflect functional heterogeneity is less clear and has been the subject of considerable debate. Recent findings particularly from knockout mouse models have provided new evidence for regional variations in myelination phenotypes, particularly between brain and spinal cord. These data raise the possibility that oligodendrocytes in these regions have different functional capacities and/or ability to compensate for loss of a specific gene. The goal of this review is to briefly revisit the evidence for oligodendrocyte heterogeneity and then to present data from transgenic and demyelinating mouse models suggesting functional heterogeneity in myelination, demyelination and remyelination in the CNS and finally, to discuss the implications of these findings for human diseases.</p>
</abstract>
<kwd-group>
<kwd>myelination oligodendrocyte progenitors</kwd>
<kwd>oligodendrocytes</kwd>
<kwd>demyelinating diseases</kwd>
<kwd>demyelination model</kwd>
<kwd>Multiple Sclerosis</kwd>
<kwd>central nervous system</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>